FDCDDQ
XERS icon

Federation des caisses Desjardins du Quebec’s Xeris Biopharma Holdings XERS Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.7K Buy
+1,500
New +$9.95K ﹤0.01% 2367
2024
Q2 		– Sell
-570
Closed -$1.26K – 2580
2024
Q1 		$1.26K Hold
570
– – ﹤0.01% 2173
2023
Q4 		$1.34K Buy
+570
New +$1.05K ﹤0.01% 2123
2022
Q2 		– Sell
-300
Closed -$768 – 2604
2022
Q1 		$768 Buy
+300
New +$733 ﹤0.01% 2453

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's XERS Position: Q1 2026 in Review

Federation des caisses Desjardins du Quebec opened a new position in Xeris Biopharma Holdings (XERS) in Q1 2026: 1,500 shares worth $8.7K. The stake represents ﹤0.01% of the portfolio and ranks #2367 among its holdings. This is a return to the name: Federation des caisses Desjardins du Quebec previously reported a position in XERS as recently as Q1 2024.

Federation des caisses Desjardins du Quebec first reported a position in XERS in Q1 2022 and has held it in 4 quarters since. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Federation des caisses Desjardins du Quebec held 1,500 shares of Xeris Biopharma Holdings worth $8.7K as of Q1 2026.
  • Xeris Biopharma Holdings was a new Federation des caisses Desjardins du Quebec position in Q1 2026.
  • Xeris Biopharma Holdings made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q1 2026, its #2367 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Xeris Biopharma Holdings in Q1 2022 and has held it in 4 quarters since.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2026, filed 14 May 2026.